-
1 Comment
Greenrose Acquisition Corp is currently in a long term downtrend where the price is trading 0.9% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Based on the above factors, Greenrose Acquisition Corp gets an overall score of 1/5.
| Exchange | OTCQX |
|---|---|
| CurrencyCode | USD |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| ISIN | US3953921034 |
| Market Cap | 2K |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 62.04 |
| Dividend Yield | None |
Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York. On June 18, 2024, The Greenrose Holding Company Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GNRS using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
